Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Bernard H CharbonnelHungta ChenJavier Cid-RuzafaAndrew CooperPeter FeniciMarília Brito GomesGabriela L SaraivaJesús MedinaAntonio NicolucciMarina V ShestakovaIichiro ShimomuraFilip SurmontFengming TangJiten VoraHirotaka WatadaKamlesh Khunti F MedScinull nullPublished in: Diabetes, obesity & metabolism (2022)
Dual oral therapy was the most common treatment regimen at the start of second-line treatment, and over half of the participants remained on the same treatment during follow-up.